Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. Listen to experts discuss a call to action for universal screening of patients with hepatitis B for coinfection with hepatitis delta.
Few treatment options exist for HDV, but many promising investigational agents are on the horizon. Listen to experts discuss what questions still need to be answered to optimize treatment of HDV with current―as well as new and emerging―agents.
The hepatitis delta virus (HDV) only coexists in patients chronically infected with hepatitis B virus (HBV). Listen to experts discuss steps to take for monitoring and treating both forms of viral hepatitis.
Several emerging agents will soon be available for the treatment of hepatitis delta virus (HDV). Hear experts discuss rational use and combinations of new agents to treat patients with HDV.
Listen as 2 experts discuss the importance of increasing healthcare professional and patient awareness of HDV to ensure that at-risk patients receive screening and then treatment and monitoring following a positive test.
Your patient tests positive for hepatitis delta virus (HDV). Now what? Listen as 2 experts discuss challenges and opportunities in linking patients with HDV to care.